CD93 and neoplasm: Furthermore, expression of IGFBP7 mutants that lose CD93 binding in tumors did not increase vessel densities as seen in tumors expressing WT IGFBP7, implicating a role of IGFBP7 in upregulating tumor angiogenesis via CD93.